Cannara Biotech Inc (LOVFF)

$1.32 0.00 (N/A)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 5,000
Avg Vol 7,686
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 0%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 a...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 514 543 4200
Website: cannara.ca
Address:
333 Decarie Blvd., Suite 200, Saint-Laurent, Canada
StreetwiseReports
StreetwiseReports Mar. 9 at 6:04 PM
Cannabis Producer Moves to the TSX as Analyst Flags Major Expansion Potential https://ow.ly/qZSR50YrsWE Cannara Biotech Inc. ($LOVE.TO; $LOVFF:OTCQX; BCB0:FSE) began trading on the Toronto Stock Exchange on March 2 after graduating from the TSX Venture Exchange. Atrium Research initiated coverage with a BUY rating and CA$3.00 target, citing best-in-class EBITDA margins of 29%.
0 · Reply
StreetwiseReports
StreetwiseReports Mar. 5 at 5:27 PM
Record Profits, a Vape Market Landgrab, and a CA$250M Facility Bought for CA$27M https://ow.ly/twTw50YpLcg Atrium Research initiated coverage on Cannara Biotech Inc. ($LOVE.TO; $LOVFF:OTCQX; BCB0:FSE), citing the company's dominant position in Quebec's new vape category, best-in-class EBITDA margins of 29%, and a capital-efficient expansion path at its Valleyfield facility that could unlock 100,000 kg of annual production capacity by FY30.
0 · Reply
Jonnny69
Jonnny69 Feb. 25 at 6:14 AM
$LUFFF $CRON $HITI $LOVFF $DB.TSXV
1 · Reply
Jonnny69
Jonnny69 Feb. 25 at 4:12 AM
$LUFFF $CRON $HITI $LOVFF $DBCCF TD Cowen initiates: Big bank just dropped fresh coverage on the Canadian cannabis space; calling it structurally improved with better pricing, scaled players finally cash-flow positive, and valuations still dirt cheap. Feels like the sector's quietly setting up for a re-rating. Who's feeling optimistic?
0 · Reply
POWGroup
POWGroup Feb. 4 at 7:59 PM
Interview: Cannara CFO Nicholas Sosiak - Earnings, Expansion Pans, AI & More #CannaraBiotech, #LOVE, #LOVFF, #Cannara, $LOVE, $LOVFF https://youtu.be/jF-RQBL1VKM
0 · Reply
Jonnny69
Jonnny69 Feb. 2 at 6:18 AM
$LUFFF $LOVFF $HITI $TCNNF $GLASF Canadain Cannabis crushing it! https://youtu.be/5oPjr_L3Wj0?si=XK285HNwMaaDKV5L
0 · Reply
gamos99
gamos99 Jan. 15 at 10:20 PM
$LOVFF Very exciting if LOVE.V can break $1.90 CDN resistance
0 · Reply
gamos99
gamos99 Dec. 12 at 5:09 PM
$LOVFF boom! Great day for Msos and LPs
0 · Reply
Jonnny69
Jonnny69 Dec. 11 at 8:24 AM
$LUFFF $TLRY $AVTBF $LOVFF $CGC “The Company stands alone in its ability to simultaneously double medical sales and provincial footprint/SKUs while tripling exports, opportunities its public peers exhausted years ago. This convergence of untapped channels positions Herbal Dispatch for the sharpest revenue acceleration in the entire public cannabis sector over the next 24-36 months.”
0 · Reply
Jonnny69
Jonnny69 Dec. 10 at 9:25 AM
$TLRY $LUFFF $AVTBF $LOVFF $CGC
0 · Reply
Latest News on LOVFF
No data available.
StreetwiseReports
StreetwiseReports Mar. 9 at 6:04 PM
Cannabis Producer Moves to the TSX as Analyst Flags Major Expansion Potential https://ow.ly/qZSR50YrsWE Cannara Biotech Inc. ($LOVE.TO; $LOVFF:OTCQX; BCB0:FSE) began trading on the Toronto Stock Exchange on March 2 after graduating from the TSX Venture Exchange. Atrium Research initiated coverage with a BUY rating and CA$3.00 target, citing best-in-class EBITDA margins of 29%.
0 · Reply
StreetwiseReports
StreetwiseReports Mar. 5 at 5:27 PM
Record Profits, a Vape Market Landgrab, and a CA$250M Facility Bought for CA$27M https://ow.ly/twTw50YpLcg Atrium Research initiated coverage on Cannara Biotech Inc. ($LOVE.TO; $LOVFF:OTCQX; BCB0:FSE), citing the company's dominant position in Quebec's new vape category, best-in-class EBITDA margins of 29%, and a capital-efficient expansion path at its Valleyfield facility that could unlock 100,000 kg of annual production capacity by FY30.
0 · Reply
Jonnny69
Jonnny69 Feb. 25 at 6:14 AM
$LUFFF $CRON $HITI $LOVFF $DB.TSXV
1 · Reply
Jonnny69
Jonnny69 Feb. 25 at 4:12 AM
$LUFFF $CRON $HITI $LOVFF $DBCCF TD Cowen initiates: Big bank just dropped fresh coverage on the Canadian cannabis space; calling it structurally improved with better pricing, scaled players finally cash-flow positive, and valuations still dirt cheap. Feels like the sector's quietly setting up for a re-rating. Who's feeling optimistic?
0 · Reply
POWGroup
POWGroup Feb. 4 at 7:59 PM
Interview: Cannara CFO Nicholas Sosiak - Earnings, Expansion Pans, AI & More #CannaraBiotech, #LOVE, #LOVFF, #Cannara, $LOVE, $LOVFF https://youtu.be/jF-RQBL1VKM
0 · Reply
Jonnny69
Jonnny69 Feb. 2 at 6:18 AM
$LUFFF $LOVFF $HITI $TCNNF $GLASF Canadain Cannabis crushing it! https://youtu.be/5oPjr_L3Wj0?si=XK285HNwMaaDKV5L
0 · Reply
gamos99
gamos99 Jan. 15 at 10:20 PM
$LOVFF Very exciting if LOVE.V can break $1.90 CDN resistance
0 · Reply
gamos99
gamos99 Dec. 12 at 5:09 PM
$LOVFF boom! Great day for Msos and LPs
0 · Reply
Jonnny69
Jonnny69 Dec. 11 at 8:24 AM
$LUFFF $TLRY $AVTBF $LOVFF $CGC “The Company stands alone in its ability to simultaneously double medical sales and provincial footprint/SKUs while tripling exports, opportunities its public peers exhausted years ago. This convergence of untapped channels positions Herbal Dispatch for the sharpest revenue acceleration in the entire public cannabis sector over the next 24-36 months.”
0 · Reply
Jonnny69
Jonnny69 Dec. 10 at 9:25 AM
$TLRY $LUFFF $AVTBF $LOVFF $CGC
0 · Reply
Jonnny69
Jonnny69 Dec. 8 at 10:52 PM
$TLRY $LUFFF $AVTBF $LOVFF $CGC All these companies got a % of this chart, up to $100M a month in exports! Expected to reach $150M a month by the end of the year!
0 · Reply
Jonnny69
Jonnny69 Dec. 8 at 10:41 PM
$LUFFF $AVTBF.US $TLRY $LOVFF $CGC All these companies got a % of this chart, up to $100M a month in exports! Expected to reach $150M a month by the end of the year!
0 · Reply
Jonnny69
Jonnny69 Dec. 8 at 8:42 PM
$LUFFF is one to watch! $LOVFF $ACB $TLRY
0 · Reply
Jonnny69
Jonnny69 Nov. 26 at 2:28 AM
$LUFFF $LOVFF $ACB $TLRY
0 · Reply
project_sharecraft
project_sharecraft Nov. 22 at 2:12 PM
$LOVFF how we feeling about Monday earnings?
0 · Reply
ackerman2436
ackerman2436 Oct. 25 at 3:07 PM
$LOVFF Doing a lot of research on this potential excise tax reform. 100% of LOVFF's income is subject to it, adding even more fuel to the bottom line. Looks like all the Canadian producers would benefit, but from what I'm seeing, LOVFF might be the best " bang for your buck " Already profitable, everything would find it's way to the bottom line. Already cheap at 10X earnings. This could be a serious sleeper. From what I understand, we'll find out Nov 4th $CRON $OGI $SNDL
1 · Reply
Buythehorns
Buythehorns Sep. 29 at 9:33 PM
$LOVFF why’d we get no love today? Cannabis industry is on a rampage. Priced in already?
0 · Reply
Mwag70
Mwag70 Aug. 26 at 10:25 PM
$LOVFF
0 · Reply
Quebecabana
Quebecabana Jul. 31 at 5:13 AM
$HITI Awareness isn't our problem--Unprofitability is. Just look at $LOVFF , a company that is virtually unknown but generating consistent profits and free cash flow, up 200% from last year. It had almost no volume last year yet here we are. High Tide has become "just another" failing cannabis stock since having a $4.5m net loss during the last two quarters. We need consistent positive EPS and strong free cash flow to get noticed. Everything else, Germany, US, 300 stores, is secondary.
4 · Reply
POWGroup
POWGroup Jul. 28 at 4:04 PM
Cannara Biotech Q3 2025 Earnings: Highest Revenue & Profitability Since Inception #CannaraBiotech, #LOVE, #LOVFF, $LOVFF, $LOVE https://youtu.be/3AmaguUWoG4
0 · Reply
chrischackal
chrischackal Jul. 28 at 1:18 PM
$LOVFF https://www.globenewswire.com/news-release/2025/07/28/3122332/0/en/Cannara-Biotech-Delivers-Highest-Revenue-and-Profitability-Since-Inception-in-Fiscal-Q3-2025.html
0 · Reply
ackerman2436
ackerman2436 Jul. 28 at 12:52 PM
$LOVFF Killer ER
1 · Reply